Drug Trial Radar · NCT02734966
Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury
Last checked: Nov 19, 2026Latest source record: Sep 27, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
174
Actual
Start
Dec 2007
Primary completion
Dec 2008
Study completion Dec 2011
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 12, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the safety, effective dosage and treatment of Magnesium Isolycyrrhizinate Injection to cure the acute drug-induced liver injury compared with the Tiopronin Injection.
Conditions
- Drug-Induced Liver Injury
Interventions
Magnesium Isoglycyrrhizinate Injection 100mg ODDrug
Magnesium Isoglycyrrhizinate Injection 100mg OD
Magnesium Isoglycyrrhizinate Injection 200mg ODDrug
Magnesium Isoglycyrrhizinate Injection 200mg OD for 4 weeks
Tiopronin InjectionDrug
Tiopronin Injection 200mg OD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of ALT normalization at week 4 of treatmentTime frame: 4 weeks
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Beijing Chest Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Nanjing Pulmonary Hospital
Nanjing, Jiangsu, China
85 Hospital of People's Liberation Army
Shanghai, Shanghai Municipality, China
Renji Hospital Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, China
Integrated Chinese and Western Medicine Hospital of Zhejiang Province
Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.